Drug details

Cytalux (pafolacianine injection)

type of Diagnostic Imaging Agents

Cytalux (pafolacianine) is an optical imaging agent indicated in adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions. 

This drug may have the following side effects:

• vomiting,
• itching
• hives, 
• difficulty breathing, 
• swelling of your face, lips, tongue, or throat, 
• abdominal pain,
• chest pain or pressure, 
• flushing (warmth, redness), 
• bloating or feeling of fullness, and 

The following drugs are related to Cytalux, either as a replacement or used together:

• Abraxane (albumin-bound paclitaxel for injectable suspension)
• Alkeran (melphalan)
• Alkeran Injection (melphalan hcl injection)
• Hexalen (altretamine)
• Avastin (bevacizumab)
• Camptosar Injection (irinotecan hydrochloride)
• Xeloda (capecitabine)
• Cosmegen (dactinomycin for injection)
• Cytoxan (cyclophosphamide)
• VePesid (etoposide)
• Toposar (etoposide injection)
• Gemzar (gemcitabine hcl)
• Hycamtin (topotecan hydrochloride)
• Hycamtin Capsules (topotecan capsules)
• Ifex (ifosfamide)
• Lynparza (olaparib capsules for oral administration)
• Zejula (niraparib capsules)
• Rubraca Tablets (rucaparib)
• Tepadina (thiotepa for injection)